AR078485A1 - Bifidobacterium longum atcc baa-999 (bl999) y control de peso - Google Patents
Bifidobacterium longum atcc baa-999 (bl999) y control de pesoInfo
- Publication number
- AR078485A1 AR078485A1 ARP100103572A ARP100103572A AR078485A1 AR 078485 A1 AR078485 A1 AR 078485A1 AR P100103572 A ARP100103572 A AR P100103572A AR P100103572 A ARP100103572 A AR P100103572A AR 078485 A1 AR078485 A1 AR 078485A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition according
- composition
- atcc baa
- weight control
- bifidobacterium longum
- Prior art date
Links
- 241001608472 Bifidobacterium longum Species 0.000 title 1
- 229940009291 bifidobacterium longum Drugs 0.000 title 1
- 238000004260 weight control Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 12
- 241000186000 Bifidobacterium Species 0.000 abstract 4
- 241000894006 Bacteria Species 0.000 abstract 2
- 235000013305 food Nutrition 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 abstract 1
- 229930091371 Fructose Natural products 0.000 abstract 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 1
- 239000005715 Fructose Substances 0.000 abstract 1
- 229920001202 Inulin Polymers 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 206010033307 Overweight Diseases 0.000 abstract 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 abstract 1
- 235000013361 beverage Nutrition 0.000 abstract 1
- 235000013325 dietary fiber Nutrition 0.000 abstract 1
- 229930182830 galactose Natural products 0.000 abstract 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 1
- 229940029339 inulin Drugs 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 229920001542 oligosaccharide Polymers 0.000 abstract 1
- 150000002482 oligosaccharides Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 235000013406 prebiotics Nutrition 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09171866A EP2308499A1 (en) | 2009-09-30 | 2009-09-30 | Bifidobacterium longum ATCC BAA-999 (BL999) and weight control |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR078485A1 true AR078485A1 (es) | 2011-11-09 |
Family
ID=41683555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100103572A AR078485A1 (es) | 2009-09-30 | 2010-09-30 | Bifidobacterium longum atcc baa-999 (bl999) y control de peso |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20120244125A1 (enExample) |
| EP (2) | EP2308499A1 (enExample) |
| JP (1) | JP5911424B2 (enExample) |
| CN (1) | CN102665737A (enExample) |
| AR (1) | AR078485A1 (enExample) |
| AU (1) | AU2010303020B2 (enExample) |
| BR (1) | BR112012007109A2 (enExample) |
| CA (1) | CA2775976A1 (enExample) |
| CL (1) | CL2012000809A1 (enExample) |
| IN (1) | IN2012DN02463A (enExample) |
| MX (1) | MX2012003612A (enExample) |
| PH (1) | PH12012500569A1 (enExample) |
| RU (1) | RU2567660C2 (enExample) |
| SG (1) | SG10201406169VA (enExample) |
| WO (1) | WO2011039176A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109069553A (zh) * | 2016-04-14 | 2018-12-21 | 杜邦营养生物科学有限公司 | 用于增加瘦体重的双歧杆菌 |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011114916A1 (ja) * | 2010-03-18 | 2011-09-22 | 森永乳業株式会社 | 貧血の予防又は治療用組成物 |
| EP2452575A1 (en) * | 2010-11-15 | 2012-05-16 | Nestec S.A. | Array of age-tailored nutritional formula with probiotics |
| FI20116008A0 (fi) | 2011-10-12 | 2011-10-12 | Maeyrae Maekinen Annika | Viskeraalisen rasvan estäminen ja diagnostisointi |
| WO2014138304A1 (en) | 2013-03-08 | 2014-09-12 | Axiom Foods, Inc., | Rice protein supplements |
| US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
| JP6234331B2 (ja) * | 2014-06-13 | 2017-11-22 | 森永乳業株式会社 | 統合失調症治療剤 |
| TWI572713B (zh) * | 2014-10-31 | 2017-03-01 | 豐華生物科技股份有限公司 | 抗肥胖之乳酸菌菌株及其於食品組成物以及醫藥組成物之應用 |
| JP6650728B2 (ja) * | 2015-03-06 | 2020-02-19 | 株式会社ファンケル | ダイエット用の製剤 |
| DK3386523T3 (da) * | 2015-12-11 | 2020-01-06 | Alimentary Health Ltd | Bifidobacterium longum til behandling af fedme og associerede metabolske sygdomme |
| JP6847577B2 (ja) * | 2015-12-28 | 2021-03-24 | 森永乳業株式会社 | ビフィドバクテリウム属細菌および／または乳酸菌の増殖促進および／または減少抑制剤 |
| IT201600105831A1 (it) * | 2016-10-20 | 2018-04-20 | Probiotical Spa | Una composizione a base di un estratto di Irvingia gabonensis e ceppi di Bifidobatteri per la regolazione e riduzione del peso corporeo |
| KR101920219B1 (ko) * | 2017-03-08 | 2018-11-20 | 서울대학교산학협력단 | 비피더스균을 포함하는 비만 예방 또는 개선용 조성물 |
| WO2018209131A1 (en) | 2017-05-12 | 2018-11-15 | Axiom Foods, Inc. | Rice products and systems and methods for making thereof |
| CA3073615A1 (en) | 2017-08-25 | 2019-02-28 | University College Cork - National University Of Ireland Cork | Bifidobacterium longum for treating obesity and weight management |
| AU2017438436B2 (en) * | 2017-10-31 | 2022-01-13 | Morinaga Milk Industry Co., Ltd. | Muscle-building composition |
| US20200345051A1 (en) | 2017-11-24 | 2020-11-05 | University College Cork, National University Of Ireland, Cork | A composition comprising a cohort of bacteria |
| WO2019199094A1 (ko) * | 2018-04-11 | 2019-10-17 | 한국생명공학연구원 | 비만의 예방 또는 치료 효과를 가지는 신규 비피도박테리움 롱검 균주 또는 락토바실러스 람노서스 균주 및 이의 용도 |
| CN111187734A (zh) * | 2019-12-25 | 2020-05-22 | 生合生物科技（扬州）有限公司 | 长双歧杆菌bl986、由其制备的冻干粉及冻干粉的应用 |
| JP7475155B2 (ja) * | 2020-02-14 | 2024-04-26 | 森永乳業株式会社 | 持久力向上用組成物 |
| JP2023526287A (ja) * | 2020-05-20 | 2023-06-21 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | ビフィドバクテリウム・ロンガムの生存性及び代謝活性に対するイネ科及び／又はマメ科繊維の有益な効果 |
| EP4070670A1 (en) | 2021-04-08 | 2022-10-12 | University College Cork-National University of Ireland Cork | Lacticaseibacillus paracasei em025-11 and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61109729A (ja) * | 1984-11-05 | 1986-05-28 | Advance Res & Dev Co Ltd | コレステロ−ル低下剤 |
| JP2687229B2 (ja) * | 1988-11-11 | 1997-12-08 | 株式会社ヤクルト本社 | 血圧降下剤 |
| JP4280016B2 (ja) * | 2002-02-28 | 2009-06-17 | 雪印乳業株式会社 | 糖尿病合併症予防・改善・治療剤 |
| JP2003252771A (ja) * | 2002-03-04 | 2003-09-10 | Snow Brand Milk Prod Co Ltd | 加齢に伴う代謝異常疾患の予防・改善・治療剤 |
| SE529185C2 (sv) * | 2005-10-07 | 2007-05-22 | Arla Foods Amba | Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt |
| JP2007169200A (ja) * | 2005-12-21 | 2007-07-05 | Morinaga Milk Ind Co Ltd | インフルエンザ感染予防のための医薬及び飲食品 |
| MX2008009726A (es) * | 2006-01-27 | 2009-03-05 | Danisco | Uso de microorganismos probioticos para el tratamiento y prevencion de la obesidad y trastornos relacionados. |
| PT1986669E (pt) * | 2006-02-15 | 2012-05-15 | Nestec Sa | Utilização de bifidobacterium longum para a prevenção e tratamento de inflamação |
| AU2007242314B2 (en) * | 2006-03-31 | 2010-07-01 | Morinaga Milk Industry Co., Ltd. | Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator |
| KR20080075971A (ko) * | 2007-02-14 | 2008-08-20 | (주)네오팜 | 프로바이오틱스 복합 제제 |
| EP1974734A1 (en) | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics for reduction of risk of obesity |
| EP2022502A1 (en) * | 2007-08-10 | 2009-02-11 | Nestec S.A. | Lactobacillus rhamnosus and weight control |
| UA31009U (uk) * | 2007-10-18 | 2008-03-25 | Одесская Национальная Академия Пищевых Технологий | Кисломолочний напій діабетичного призначення |
| UA30077U (uk) * | 2007-10-18 | 2008-02-11 | Одесская Национальная Академия Пищевых Технологий | Композиція для йогурту діабетичного призначення |
| JP2009143820A (ja) * | 2007-12-12 | 2009-07-02 | Tsujido Chemical Corp | 高尿酸血症の予防または改善剤 |
-
2009
- 2009-09-30 EP EP09171866A patent/EP2308499A1/en not_active Withdrawn
-
2010
- 2010-09-28 SG SG10201406169VA patent/SG10201406169VA/en unknown
- 2010-09-28 EP EP10760993A patent/EP2482829A1/en not_active Withdrawn
- 2010-09-28 PH PH1/2012/500569A patent/PH12012500569A1/en unknown
- 2010-09-28 MX MX2012003612A patent/MX2012003612A/es not_active Application Discontinuation
- 2010-09-28 JP JP2012531354A patent/JP5911424B2/ja not_active Ceased
- 2010-09-28 US US13/499,535 patent/US20120244125A1/en not_active Abandoned
- 2010-09-28 CA CA2775976A patent/CA2775976A1/en not_active Abandoned
- 2010-09-28 IN IN2463DEN2012 patent/IN2012DN02463A/en unknown
- 2010-09-28 WO PCT/EP2010/064348 patent/WO2011039176A1/en not_active Ceased
- 2010-09-28 CN CN2010800437884A patent/CN102665737A/zh active Pending
- 2010-09-28 AU AU2010303020A patent/AU2010303020B2/en not_active Ceased
- 2010-09-28 RU RU2012117804/10A patent/RU2567660C2/ru not_active IP Right Cessation
- 2010-09-28 BR BR112012007109A patent/BR112012007109A2/pt not_active IP Right Cessation
- 2010-09-30 AR ARP100103572A patent/AR078485A1/es unknown
-
2012
- 2012-03-30 CL CL2012000809A patent/CL2012000809A1/es unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109069553A (zh) * | 2016-04-14 | 2018-12-21 | 杜邦营养生物科学有限公司 | 用于增加瘦体重的双歧杆菌 |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2012003612A (es) | 2012-04-19 |
| US20120244125A1 (en) | 2012-09-27 |
| RU2567660C2 (ru) | 2015-11-10 |
| JP5911424B2 (ja) | 2016-04-27 |
| BR112012007109A2 (pt) | 2016-07-05 |
| WO2011039176A1 (en) | 2011-04-07 |
| CL2012000809A1 (es) | 2012-07-13 |
| IN2012DN02463A (enExample) | 2015-05-22 |
| JP2013506631A (ja) | 2013-02-28 |
| CN102665737A (zh) | 2012-09-12 |
| EP2482829A1 (en) | 2012-08-08 |
| EP2308499A1 (en) | 2011-04-13 |
| PH12012500569A1 (en) | 2012-10-22 |
| AU2010303020A1 (en) | 2012-04-19 |
| SG10201406169VA (en) | 2014-11-27 |
| CA2775976A1 (en) | 2011-04-07 |
| AU2010303020B2 (en) | 2014-11-20 |
| RU2012117804A (ru) | 2013-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR078485A1 (es) | Bifidobacterium longum atcc baa-999 (bl999) y control de peso | |
| AR067906A1 (es) | Lactobacillus rhamnosus y control del peso | |
| Woo et al. | Lactobacillus pentosus var. plantarum C29 ameliorates memory impairment and inflammaging in a D-galactose-induced accelerated aging mouse model | |
| Sekhon et al. | Prebiotics, probiotics and synbiotics: an overview. | |
| AU2010311325B2 (en) | Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof | |
| DK2672980T3 (en) | SYNBIOTIC COMPOSITIONS FOR GETTING UP AND RECONSTITUTING GAS MICROFLORA | |
| RU2012111253A (ru) | Bifidobacterium longum и функциональные расстройства желудочно-кишечного тракта | |
| Tomar et al. | Role of probiotics, prebiotics, synbiotics and postbiotics in inhibition of pathogens | |
| AR067971A1 (es) | Uso de composicion para la prevencion y/o tratamiento de desordenes metabolicos | |
| AR076862A1 (es) | Microorganismos no replicantes y su efecto de refuerzo inmunologico. composicion. metodo para aumentar efectividad de probioticos | |
| ES2989117T3 (es) | Prebióticos para reducir el riesgo de obesidad más tarde en la vida | |
| CN113226062A (zh) | 包含2’-岩藻糖基乳糖（2’fl）以改善胃肠屏障的营养组合物 | |
| BR112016018283A2 (pt) | Composição que compreende bifidobacterium animalis ssp. lactis | |
| CL2008000928A1 (es) | Uso de bacterias probioticas de las especies lactobacillus rhamnosus, cepas atcc 53103 ó cgmcc 13724 para la fabaricacion de un medicamento o formula infantil que permite reducir el riesgo de que el infante desarrolle obesidad a lo largo de su vida. | |
| MX337667B (es) | Combinacion simbiotica para mejorar la microbiota intestinal. | |
| BR112013004194A2 (pt) | produto simbiótico | |
| BR112019001984A2 (pt) | bactérias lácticas e a sua utilização para tratamento prevenção, inibição e/ou redução da formação de biofilmes bacterianos | |
| ATE463558T1 (de) | Beta-galactosidase mit transgalactosylierungsaktivität | |
| RU2018139655A (ru) | Бифидобактерии для увеличения безжировой массы тела | |
| FI20065593A7 (fi) | Menetelmä galakto-oligosakkarideja sisältävien tuotteiden valmistamiseksi ja niiden käyttö | |
| RU2018145729A (ru) | Композиции и способы для маленьких животных из семейства собачьих | |
| CN113925923A (zh) | 一种抗痘美白的复合益生菌组合物及其制备方法 | |
| RU2018139656A (ru) | Бифидобактерии для снижения потребления пищи, энергии и/или жиров | |
| KR20240037256A (ko) | 생리학적으로 허용되는 효모 조성물 및 이의 용도 | |
| Yu et al. | Mucin2 is Required for Probiotic Agents-Mediated Blocking Effects on Meningitic E. coli-Induced Pathogenicities S |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |